Decoding multifocal hepatocellular carcinoma: an opportune pursuit
View/ Open
HBSN-14-146.pdf (232.7Kb)
Access Status
Full text of the requested work is not available in DASH at this time ("restricted access"). For more information on restricted deposits, see our FAQ.Author
Metadata
Show full item recordCitation
Baffy, Gyorgy. 2015. Decoding multifocal hepatocellular carcinoma: an opportune pursuit. Hepatobiliary Surgery and Nutrition 4 (3): 206-10.Abstract
Hepatocellular carcinoma (HCC) is a malignancy with major worldwide prevalence and a poor overall prognosis. About 75% of all HCC cases are initially diagnosed as multiple tumors, presenting a particular challenge for aggressive surgical therapy. Multiple HCC may result from multicentric occurrence (MO-HCC) or intrahepatic metastases (IM-HCC), corresponding to highly dissimilar clinical outcomes. Reliable distinction of these two mechanisms is therefore paramount in optimizing the management of multiple HCC. In a recent work, Miao et al. adopted a multi-omics approach to find key parameters of different clonality in MO-HCC vs. IM-HCC and link these data to tumor behavior and prognosis in a cohort of patients with HBV-related HCC. The mitotic checkpoint regulator TTK has emerged from this analysis as a novel biomarker that may predict aggressive behavior and early postoperative recurrence of HCC.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4465603/Citable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:42658680
Collections
- HMS Scholarly Articles [17922]
Contact administrator regarding this item (to report mistakes or request changes)